IMBYODIF
DEAD
Serial Number
90807748
Owner
Summit Therapeutics Inc.Attorney
Andrew D. BochnerFiling Date
Jul 1, 2021
IMBYODIF Trademark
Serial Number: 90807748
IMBYODIF is a trademark filed by
Summit Therapeutics Inc.
on July 1, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently no longer active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
July 1, 2021
Registration Date
Not Registered
Published for Opposition
September 14, 2021
Goods & Services
Pharmaceutical preparations for treatment of Clostridioides difficile infection; Pharmaceutical compositions for the treatment of Clostridioides difficile infection; Pharmaceutical formulations for the treatment of Clostridioides difficile infection; Antibiotics
Filing History
ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Dec 28, 2021 MAB5
ABANDONMENT - AFTER PUBLICATION
Dec 28, 2021 ABN5
TEAS EXPRESS ABANDONMENT RECEIVED
Dec 20, 2021 EXAR
EXTENSION OF TIME TO OPPOSE RECEIVED
Oct 1, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 14, 2021 NPUB
PUBLISHED FOR OPPOSITION
Sep 14, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 26, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 11, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 10, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 10, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 10, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 10, 2021 CNEA
ASSIGNED TO EXAMINER
Aug 5, 2021 DOCK
ASSIGNED TO EXAMINER
Aug 5, 2021 DOCK
PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED
Aug 5, 2021 PMSG
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2021 NWOS
ASSIGNED TO PETITION STAFF
Aug 3, 2021 APET
TEAS PETITION TO DIRECTOR-MAKE SPECIAL-RECEIVED
Jul 30, 2021 TPMS
NEW APPLICATION ENTERED
Jul 5, 2021 NWAP
